Literature DB >> 14283036

COMPARISON OF THE SOLUBLE ANTIGENS AND VIRUS PARTICLE ANTIGENS OF VACCINIA VIRUS.

J C WESTWOOD, H T ZWARTOUW, G APPLEYARD, D H TITMUSS.   

Abstract

Entities:  

Keywords:  ANTIGENS; ENZYMES; EXPERIMENTAL LAB STUDY; GEL DIFFUSION TESTS; IMMUNOCHEMISTRY; METABOLISM; PRECIPITIN TESTS; RABBITS; TISSUE CULTURE; VACCINIA; VACCINIA VIRUS

Mesh：

Substances：

Year:  1965        PMID： 14283036     DOI： 10.1099/00221287-38-1-47

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN： 0022-1287


× No keyword cloud information.
  9 in total

Review 1.  Recent progress in poxvirus research.

Authors:  B Woodson
Journal:  Bacteriol Rev       Date:  1968-06

2.  Studies on the LS antigen of vaccinia virus.

Authors:  C J Rondle; J D Williamson
Journal:  J Hyg (Lond)       Date:  1968-09

3.  Soluble antigens of vaccinia-infected mammalian cells. 3. Relation of "early" and "late" proteins to virus structure.

Authors:  G H Cohen; W C Wilcox
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

Review 4.  The poxviruses.

Authors:  W K Joklik
Journal:  Bacteriol Rev       Date:  1966-03

5.  Serological characterization of buffalopox virus.

Authors:  S M Lal; I P Singh
Journal:  Arch Gesamte Virusforsch       Date:  1973

6.  [Host cell-dependent density differencies of the intra- and extraviral vaccinia virus hemagglutinins].

Authors:  W Schiek
Journal:  Arch Gesamte Virusforsch       Date:  1974

7.  Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication.

Authors:  N P Salzman; E D Sebring
Journal:  J Virol       Date:  1967-02       Impact factor: 5.103

8.  A comparison of the antigens present on the surface of virus released artificially from chick cells infected with vaccinia virus, and cowpox virus and its white pock mutant.

Authors:  D Baxby
Journal:  J Hyg (Lond)       Date:  1972-06

9.  Immunodiffusion analysis of Yaba poxvirus structural and associated antigens.

Authors:  R G Olsen; D S Yohn
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.